Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Change in Cash (2016 - 2025)

Historic Change in Cash for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $458000.0.

  • Marimed's Change in Cash rose 21336.63% to $458000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 million, marking a year-over-year increase of 803.8%. This contributed to the annual value of -$7.4 million for FY2024, which is 25002.04% down from last year.
  • Marimed's Change in Cash amounted to $458000.0 in Q3 2025, which was up 21336.63% from -$1.1 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Change in Cash registered a high of $11.9 million during Q1 2023, and its lowest value of -$25.6 million during Q2 2022.
  • Over the past 5 years, Marimed's median Change in Cash value was $458000.0 (recorded in 2025), while the average stood at $189315.8.
  • As far as peak fluctuations go, Marimed's Change in Cash skyrocketed by 1060547.37% in 2021, and later plummeted by 60726.48% in 2022.
  • Marimed's Change in Cash (Quarter) stood at $4.1 million in 2021, then plummeted by 133.54% to -$1.4 million in 2022, then skyrocketed by 200.73% to $1.4 million in 2023, then plummeted by 280.81% to -$2.5 million in 2024, then surged by 118.28% to $458000.0 in 2025.
  • Its Change in Cash was $458000.0 in Q3 2025, compared to -$1.1 million in Q2 2025 and -$81000.0 in Q1 2025.